Magnus Financial Group’s Insys Therapeutics, Inc. INSY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-13,393
Closed -$62K 594
2019
Q1
$62K Hold
13,393
0.01% 506
2018
Q4
$47K Buy
+13,393
New +$93.1K 0.01% 435

Other funds holding INSY

Magnus Financial Group's INSY Position: Q2 2019 in Review

Magnus Financial Group sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 13,393 shares — an estimated $62K sold.

Magnus Financial Group first reported a position in INSY in Q4 2018 and held it in 2 quarters. The position peaked at $62K in Q1 2019. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • Magnus Financial Group reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Magnus Financial Group sold 13,393 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $62K.
  • Magnus Financial Group first reported a position in Insys Therapeutics, Inc. in Q4 2018 and held it in 2 quarters.
  • Magnus Financial Group's Insys Therapeutics, Inc. position peaked at $62K in Q1 2019.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Magnus Financial Group's 13F filing for Q2 2019, filed 5 Aug 2019.